Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hiroaki,Ikesue

第一单位： Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan ikesue@pharm.med.kyushu-u.ac.jp.

作者： Hiroaki,Ikesue ^[1] ; Toshikazu,Tsuji ^[2] ; Koujiro,Hata ^[2] ; Hiroyuki,Watanabe ^[2] ; Kazuto,Mishima ^[2] ; Mayako,Uchida ^[2] ; Nobuaki,Egashira ^[2] ; Toshihiro,Miyamoto ^[3] ; Eishi,Baba ^[4] ; Koichi,Akashi ^[3] ; Koichi,Takayama ^[5] ; Yoichi,Nakanishi ^[5] ; Eriko,Tokunaga ^[4] ; Tatsuro,Okamoto ^[6] ; Yoshihiko,Maehara ^[6] ; Akira,Yokomizo ^[7] ; Seiji,Naito ^[7] ; Makoto,Kubo ^[8] ; Masao,Tanaka ^[8] ; Satohiro,Masuda ^[2]

作者单位： Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan ikesue@pharm.med.kyushu-u.ac.jp. ^[1] Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan. ^[2] Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University. ^[3] Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University. ^[4] Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University. ^[5] Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University. ^[6] Department of Urology, Graduate School of Medical Sciences, Kyushu University. ^[7] Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University. ^[8]

关键词 denosumab glomerular filtration rate hypocalcemia kidney dysfunction risk factor

DOI 10.1177/1060028014539919

PMID 24928100

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交